36 related articles for article (PubMed ID: 23238827)
1. Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates.
Schneider JS; Decamp E; Koser AJ; Fritz S; Gonczi H; Syversen T; Guilarte TR
Brain Res; 2006 Nov; 1118(1):222-31. PubMed ID: 16978592
[TBL] [Abstract][Full Text] [Related]
2. Moderating effects of uric acid and sex on cognition and psychiatric symptoms in asymmetric Parkinson's disease.
Constantin IM; Voruz P; Péron JA
Biol Sex Differ; 2023 May; 14(1):26. PubMed ID: 37143121
[TBL] [Abstract][Full Text] [Related]
3. Development and Co-design of NeuroOrb: A Novel "Serious Gaming" System Targeting Cognitive Impairment in Parkinson's Disease.
Guglietti B; Hobbs DA; Wesson B; Ellul B; McNamara A; Drum S; Collins-Praino LE
Front Aging Neurosci; 2022; 14():728212. PubMed ID: 35422697
[TBL] [Abstract][Full Text] [Related]
4. Experimental Models of Cognitive Impairment for Use in Parkinson's Disease Research: The Distance Between Reality and Ideal.
Fan Y; Han J; Zhao L; Wu C; Wu P; Huang Z; Hao X; Ji Y; Chen D; Zhu M
Front Aging Neurosci; 2021; 13():745438. PubMed ID: 34912207
[TBL] [Abstract][Full Text] [Related]
5. Transplantation site influences the phenotypic differentiation of dopamine neurons in ventral mesencephalic grafts in Parkinsonian rats.
Fjodorova M; Torres EM; Dunnett SB
Exp Neurol; 2017 May; 291():8-19. PubMed ID: 28131726
[TBL] [Abstract][Full Text] [Related]
6. Toxin-Induced Experimental Models of Learning and Memory Impairment.
More SV; Kumar H; Cho DY; Yun YS; Choi DK
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598124
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease.
Lelos MJ; Morgan RJ; Kelly CM; Torres EM; Rosser AE; Dunnett SB
Exp Neurol; 2016 Apr; 278():54-61. PubMed ID: 26851542
[TBL] [Abstract][Full Text] [Related]
8. Pueraria mirifica extract and puerarin enhance proliferation and expression of alkaline phosphatase and type I collagen in primary baboon osteoblasts.
Tiyasatkulkovit W; Malaivijitnond S; Charoenphandhu N; Havill LM; Ford AL; VandeBerg JL
Phytomedicine; 2014 Oct; 21(12):1498-503. PubMed ID: 25442257
[TBL] [Abstract][Full Text] [Related]
9. The neurobiological basis of cognitive impairment in Parkinson's disease.
Halliday GM; Leverenz JB; Schneider JS; Adler CH
Mov Disord; 2014 Apr; 29(5):634-50. PubMed ID: 24757112
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.
Stewart T; Liu C; Ginghina C; Cain KC; Auinger P; Cholerton B; Shi M; Zhang J;
Am J Pathol; 2014 Apr; 184(4):966-975. PubMed ID: 24625392
[TBL] [Abstract][Full Text] [Related]
11. Cognitive dysfunction precedes the onset of motor symptoms in the MitoPark mouse model of Parkinson's disease.
Li X; Redus L; Chen C; Martinez PA; Strong R; Li S; O'Connor JC
PLoS One; 2013; 8(8):e71341. PubMed ID: 23977020
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models.
Ko WKD; Camus SM; Li Q; Yang J; McGuire S; Pioli EY; Bezard E
Neuropharmacology; 2016 Nov; 110(Pt A):48-58. PubMed ID: 27424102
[TBL] [Abstract][Full Text] [Related]
13. A novel adenosine A(1) and A(2A) receptor antagonist ASP5854 ameliorates motor impairment in MPTP-treated marmosets: comparison with existing anti-Parkinson's disease drugs.
Mihara T; Iwashita A; Matsuoka N
Behav Brain Res; 2008 Dec; 194(2):152-61. PubMed ID: 18657577
[TBL] [Abstract][Full Text] [Related]
14. Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys.
Schneider JS; Tinker JP; Van Velson M; Menzaghi F; Lloyd GK
J Pharmacol Exp Ther; 1999 Aug; 290(2):731-9. PubMed ID: 10411585
[TBL] [Abstract][Full Text] [Related]
15. The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future.
Fox SH; Brotchie JM
Prog Brain Res; 2010; 184():133-57. PubMed ID: 20887873
[TBL] [Abstract][Full Text] [Related]
16. Levodopa improves motor deficits but can further disrupt cognition in a macaque Parkinson model.
Schneider JS; Pioli EY; Jianzhong Y; Li Q; Bezard E
Mov Disord; 2013 May; 28(5):663-7. PubMed ID: 23238827
[TBL] [Abstract][Full Text] [Related]
17. Effects of the nicotinic acetylcholine receptor agonist SIB-1508Y on object retrieval performance in MPTP-treated monkeys: comparison with levodopa treatment.
Schneider JS; Van Velson M; Menzaghi F; Lloyd GK
Ann Neurol; 1998 Mar; 43(3):311-7. PubMed ID: 9506547
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
